Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors
    6.
    发明授权
    Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors 失效
    缩合环吡啶化合物作为鞘氨醇-1-磷酸-2(S1P2)受体的亚型选择性调节剂

    公开(公告)号:US08507682B2

    公开(公告)日:2013-08-13

    申请号:US13498499

    申请日:2010-09-28

    CPC分类号: C07D471/04 C07D215/38

    摘要: The invention provides compounds represented by the formula I, each of which compounds may have sphingosine-1-phosphate receptor agonist and or antagonist biological activity, wherein these compounds selected from the group consisting of wherein A, B, C, D, X, Y, Z and R3 are defined in the specification. Said compounds are useful for treating a disease or condition of a mammal selected from the group consisting of ocular diseases; systemic vascular barrier related diseases; allergies and other inflammatory diseases; cardiac diseases or conditions; fibrosis; pain and wounds.

    摘要翻译: 本发明提供由式I表示的化合物,其中每一种化合物可具有鞘氨醇-1-磷酸受体激动剂和/或拮抗剂生物活性,其中这些化合物选自其中A,B,C,D,X, Y,Z和R3在本说明书中定义。 所述化合物可用于治疗选自眼部疾病的哺乳动物的疾病或病症; 全身血管屏障相关疾病; 过敏等炎症疾病; 心脏疾病或病症; 纤维化; 疼痛和伤口。